D000318Chemicals & DrugsD27.505.519.625.050.100.200D27.505.696.577.050.100.20016480.971848Adrenergic beta-AgonistsFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentvivo:hrJobTitleHR job titleInformation ResourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson24369795Ortega VE, Meyers DAThe Journal of allergy and clinical immunologyOrtega VE, Meyers DA. Pharmacogenetics: implications of race and ethnicity on defining genetic profiles for personalized medicine. J Allergy Clin Immunol. 2014 Jan; 133(1):16-26.J Allergy Clin Immunol2014-01-01T00:00:002014Pharmacogenetics: implications of race and ethnicity on defining genetic profiles for personalized medicine.24621682Ortega VE, Hawkins GA, Moore WC, Hastie AT, Ampleford EJ, Busse WW, Castro M, Chardon D, Erzurum SC, Israel E, Montealegre F, Wenzel SE, Peters SP, Meyers DA, Bleecker ERThe Lancet. Respiratory medicineOrtega VE, Hawkins GA, Moore WC, Hastie AT, Ampleford EJ, Busse WW, Castro M, Chardon D, Erzurum SC, Israel E, Montealegre F, Wenzel SE, Peters SP, Meyers DA, Bleecker ER. Effect of rare variants in ADRB2 on risk of severe exacerbations and symptom control during longacting ß agonist treatment in a multiethnic asthma population: a genetic study. Lancet Respir Med. 2014 Mar; 2(3):204-13.Lancet Respir Med2014-01-27T00:00:002014Effect of rare variants in ADRB2 on risk of severe exacerbations and symptom control during longacting ß agonist treatment in a multiethnic asthma population: a genetic study.24794577Meyers DA, Bleecker ER, Holloway JW, Holgate STThe Lancet. Respiratory medicineMeyers DA, Bleecker ER, Holloway JW, Holgate ST. Asthma genetics and personalised medicine. Lancet Respir Med. 2014 May; 2(5):405-15.Lancet Respir Med2014-05-02T00:00:002014Asthma genetics and personalised medicine.BiochemistryPathologyWake Forest School of MedicineGregoryHawkinsGregory A. Hawkins PhD36.09040200000000-80.26700599999999308Hawkins, GregoryProfessorAnnetteHastieAnnette T. Hastie PhD36.09040200000000-80.2670059999999931Hastie, AnnetteProfessorJillOharJill Ohar MD36.08919100000000-80.26677800000000458Ohar, JillProfessorStephenPetersStephen Peters MD, PhD36.09040200000000-80.26700599999999927Peters, StephenProfessor27609408Bleecker ER, FitzGerald JM, Chanez P, Papi A, Weinstein SF, Barker P, Sproule S, Gilmartin G, Aurivillius M, Werkström V, Goldman MLancet (London, England)Bleecker ER, FitzGerald JM, Chanez P, Papi A, Weinstein SF, Barker P, Sproule S, Gilmartin G, Aurivillius M, Werkström V, Goldman M. Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting ß2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial. Lancet. 2016 10 29; 388(10056):2115-2127.Lancet2016-09-05T00:00:002016Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting ß2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial.30423011Ohar J, Putcha N, Bradshaw MThe Journal of family practiceOhar J, Putcha N, Bradshaw M. Asthma-Chronic Obstructive Pulmonary Disease Overlap: Diagnostic and Management Challenges. J Fam Pract. 2018 10; 67(10 Suppl):S46-S51.J Fam Pract2018-10-01T00:00:002018Asthma-Chronic Obstructive Pulmonary Disease Overlap: Diagnostic and Management Challenges.22Associate ProfessorAlinaSofronescuAlina G. Sofronescu PhD2606Sofronescu, AlinaAssociate ProfessorInternal Medicine, Pulmonary, Critical Care, Allergy and Immunologic Diseasestrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1Associate ProfessorAssociate Professor2.495960.011713116research area of0.6871640.048209564subject area for